NCT02030613View on ClinicalTrials.gov

Effective Dose of Etanercept in Patients Treated for Juvenile Idiopathic Arthritis

NACompletedINTERVENTIONAL
Enrollment

126

Participants

Timeline

Start Date

October 1, 2013

Primary Completion Date

February 28, 2017

Study Completion Date

March 30, 2017

Conditions
Juvenile Idiopathic Arthritis
Interventions
GENETIC

Blood test

Trial Locations (1)

75015

Hospital Necker, Paris

All Listed Sponsors
lead

Assistance Publique - Hôpitaux de Paris

OTHER

NCT02030613 - Effective Dose of Etanercept in Patients Treated for Juvenile Idiopathic Arthritis | Biotech Hunter | Biotech Hunter